Patrick Robert Verhoest
58Patents
6h-index
86Co-inventors
75Inventor score
Filing activity: Nov 15, 2002 → Aug 12, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6992087B2 | Substituted aryl 1,4-pyrazine derivatives | Emerging Cross-Sectional Technologies | 61 | Expired |
| US7041672B2 | Substituted aryl 1, 4-pyrazine derivatives | Emerging Cross-Sectional Technologies | 56 | Expired |
| US7964607B2 | Pyrazolo[3,4-d]pyrimidine compounds | Human Necessities | 30 | Active |
| US8598155B2 | Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders | Human Necessities | 18 | Active |
| US7429665B2 | Heteroaromatic quinoline compounds | Chemistry; Metallurgy | 17 | Active |
| US10039753B2 | Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors | Chemistry; Metallurgy | 9 | Active |
| US9611264B1 | N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides | Human Necessities | 6 | Active |
| US9695171B2 | 3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors | Chemistry; Metallurgy | 6 | Active |
| US9120788B2 | Azabenzimidazole compounds | Human Necessities | 6 | Active |
| US8916564B2 | Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders | Human Necessities | 5 | Active |
| US7087617B2 | Substituted pyrimidine derivatives | Chemistry; Metallurgy | 5 | Expired |
| US9845301B2 | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors | Chemistry; Metallurgy | 5 | Active |
| US9598421B2 | Imidazopyridazine compounds | Chemistry; Metallurgy | 4 | Active |
| US8618117B2 | Amino-heterocyclic compounds | Human Necessities | 3 | Active |
| US7825254B2 | Heteroaromatic quinoline compounds | Chemistry; Metallurgy | 3 | Active |
| US8183238B2 | Bicyclic and tricyclic compounds as KAT II inhibitors | Chemistry; Metallurgy | 3 | Active |
| US8278295B2 | Amino-heterocyclic compounds | Human Necessities | 3 | Active |
| US9200000B2 | Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders | Human Necessities | 3 | Active |
| US8933224B2 | Triazine derivatives | Chemistry; Metallurgy | 3 | Active |
| US9156845B2 | 4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitors | Chemistry; Metallurgy | 3 | Active |
| US7015229B2 | Substituted pyrimidinones and pyrimidinthiones | Physics | 2 | Expired |
| US10738063B2 | 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds | Chemistry; Metallurgy | 2 | Active |
| US10328082B2 | Methods of use and combinations | Human Necessities | 2 | Active |
| US9642855B2 | Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9145427B2 | Triazine derivatives | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.